Gadodiamide

Results: 44



#Item
11Nephrogenic systemic fibrosis / Nephrology / Gadodiamide / Gadopentetic acid / Gadolinium / Magnetic resonance imaging / Gadobutrol / Gadobenic acid / Chronic kidney disease / Chemistry / Matter / Medicine

Microsoft Word - MH Briefing Document -Final.doc

Add to Reading List

Source URL: www.fda.gov

Language: English
12Nephrology / Gadopentetic acid / Gadolinium / Gadodiamide / Magnetic resonance imaging / Pentetic acid / Schering AG / Gadoteridol / Contrast medium / Chemistry / Matter / Nephrogenic systemic fibrosis

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived

Add to Reading List

Source URL: www.fda.gov

Language: English
13Magnetic resonance imaging / Gadodiamide / Medical imaging / Gadopentetic acid / Nephrogenic systemic fibrosis / Gadoteridol / Gadolinium / Chemistry / Medicine / Matter

[removed]Gadobutrol Statistical PREA

Add to Reading List

Source URL: www.fda.gov

Language: English
14Nephrogenic systemic fibrosis / Nephrology / Gadodiamide / Gadopentetic acid / Gadolinium / Magnetic resonance imaging / Hepatorenal syndrome / Gadoteridol / Contrast medium / Chemistry / Matter / Medicine

Microsoft Word - DDR letter - final with signatures[removed]mcm.doc

Add to Reading List

Source URL: www.fda.gov

Language: English
15Gadolinium / Magnetic resonance imaging / Gadopentetic acid / Food and Drug Administration / Nephrogenic systemic fibrosis / MRI contrast agent / Chemistry / Matter / Gadodiamide

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

Add to Reading List

Source URL: www.fda.gov

Language: English
16Nephrogenic systemic fibrosis / Gadopentetic acid / Gadolinium / Magnetic resonance imaging / Pentetic acid / MRI contrast agent / Chemistry / Matter / Gadodiamide

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

Add to Reading List

Source URL: www.fda.gov

Language: English
17MRI contrast agent / Gadodiamide / Magnetic resonance imaging / Pentetic acid / Food and Drug Administration / Medical imaging / Chemistry / Medicine / Gadopentetic acid

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

Add to Reading List

Source URL: www.fda.gov

Language: English
18Nephrology / Gadodiamide / Gadolinium / Magnetic resonance imaging / Gadoteridol / Gadopentetic acid / Renal failure / MRI contrast agent / Nephrogenic systemic fibrosis / Chemistry / Matter / Medicine

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

Add to Reading List

Source URL: www.fda.gov

Language: English
19Health / Pharmacology / Adverse effect / Methadone / Chemistry / Medicine / Gadodiamide

Microsoft PowerPoint - GEHC_Presentation_FINAL.ppt

Add to Reading List

Source URL: www.fda.gov

Language: English
20Gadolinium / Gadodiamide / Pentetic acid / Bayer HealthCare Pharmaceuticals / Gadobenic acid / Food and Drug Administration / Chemistry / Matter / Gadopentetic acid

Eovist® (Gadoxetate disodium)

Add to Reading List

Source URL: www.fda.gov

Language: English
UPDATE